In terms of further histological/molecular features of DLBCL, one patient with clonally related lymphoma was a double expressor of MYC and BCL2, and one presented with CD5+ aggressive lymphoma following an initially CD5− MALT lymphoma. The gene discussed is BCL2; the disease is MALT lymphoma.